Pick out other agents are proposed as substitute brokers according to administration troubles and/or adverse result profile.  Zidovudine combined with lamivudine is the alternative NRTI backbone but is affiliated with far more hematologic toxicity. Lopinavir/ritonavir is another PI agent with f